Cancer News and Research

Latest Cancer News and Research

New Aspen Dental office to open in Springdale

Patients looking for a dentist in Springdale, OH now have a new dental care provider option with the opening of a new Aspen Dental office this month. The new practice, which opens on August 4th at 25 East Kemper Road, will provide dental services that range from dentures and preventive care to general dentistry and restoration.

30 Jul 2011

New Aspen Dental office to open in N. Lakeland in August

Patients looking for a dentist in N. Lakeland, FL now have a new dental care provider option with the opening of a new Aspen Dental office this month.

30 Jul 2011

Spectros reports 51% increase in year-to-date Oximeter sales revenue for 2011

Spectros Corporation announced today that 2011 year-to-date sales revenue rose 51% over the similar period in 2010.

30 Jul 2011

UCSD researchers examine association of energy balance, breast cancer

A team of researchers from the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center will be participating in a cooperative agreement initiative, funded by the National Cancer Institute of the National Institutes of Health, with four other major cancer centers.

30 Jul 2011

Eight in ten Ontarians expect better access to trauma centre for life-threatening injury

More than eight in 10 Ontarians say they would want to be taken directly to a trauma centre if they were seriously injured, even if another hospital were closer, a new poll has found.

30 Jul 2011

New fluorescent tool can track mysterious workings of cellular RNAs

The ability to tag proteins with a green fluorescent light to watch how they behave inside cells so revolutionized the understanding of protein biology that it earned the scientific teams who developed the technique Nobel Prizes in 2008.

30 Jul 2011

Canadian Cancer Society praises Supreme Court judgment against tobacco industry

The Supreme Court of Canada today unanimously decided that if the tobacco industry is forced to pay damages to the BC government for tobacco-related health care costs, the federal government will not be required to reimburse the tobacco industry for those damages.

30 Jul 2011

Humira defect lawyers file lawsuit against Abbott in Texas state court

Humira defect lawyers filed a lawsuit against Abbott Laboratories in Texas state court claiming Abbott's blockbuster drug, Humira, caused a life-threatening disease, leukemia.

30 Jul 2011

Varian Medical Systems signs agreement with CIVCO to offer Body Pro-Lok to its customers

CIVCO is pleased to announce the signing of a reseller agreement that would allow Varian Medical Systems to offer CIVCO's Body Pro-Lok to its customers.

30 Jul 2011

UH Rainbow physicians to participate in two new clinical trials with AsthmaNet

Physicians at University Hospitals (UH) Rainbow Babies and Children's Hospital are participating in two new clinical trials with the national research consortium AsthmaNet.

30 Jul 2011

ORENCIA SC formulation receives FDA approval for treatment of adults with RA

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a subcutaneous formulation of ORENCIA (abatacept) for the treatment of adults with moderate to severe rheumatoid arthritis.

30 Jul 2011

Physicians to provide high-quality care, training to medically underserved community

Today, the first class of Texas Children's Global Health Corps will depart Houston for assignment in Africa. This talented team of pediatricians and family doctors will provide medical care and treatment to thousands of children and families affected by serious or life-threatening medical conditions, including sickle cell disease, malaria, tuberculosis, malnutrition, cancer and HIV/AIDS.

30 Jul 2011

Heart disease remains most costly condition in terms of health care expenditure for women: AHRQ

The cost of treating women for heart disease in 2008 was $43.6 billion, leading a list of the top 10 most expensive conditions for women, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

30 Jul 2011

Cancer patients should stick to basic sun-protection guidelines, experts say

Summer often brings with it fun in the sun, but for cancer patients it also presents new challenges and the need for additional protection.

30 Jul 2011

CJ, RaQualia sign license agreement to develop and commercialize RQ-00000010 Partial Agonist

RaQualia Pharma Inc. today announced the signing of a license agreement with CJ CheilJedang Co. (CJ), granting CJ exclusive rights to develop, manufacture and commercialize RaQualia's 5-HT4 Partial Agonist in Korea, China, Taiwan, India and Southeast Asia.

30 Jul 2011

WU researchers receive NCI grant to study link between obesity and cancer

Researchers at Washington University School of Medicine in St. Louis have been awarded a $9.2 million grant from the National Cancer Institute (NCI) to study the relationship between obesity and cancer.

30 Jul 2011

Viewpoints: Sanders on angry Americans; Sebelius on Md. exchanges; Samuelson: 'it's the elderly, stupid'

If the Republicans have their way, the entire burden of deficit reduction will be placed on the elderly, the sick, children and working families. In the midst of a horrendous recession that is already causing severe pain for average Americans, this approach is morally grotesque. ... The Reid plan is bad. The constantly shifting plan by House Speaker John Boehner is much worse. ... Those cuts would mean drastic reductions in Social Security, Medicare and Medicaid.

30 Jul 2011

EGT transfers clinical grade lentiviral vector to MSKCC

Errant Gene Therapeutics, LLC, a pioneering boutique drug development firm specializing in Rare Diseases, announced the transfer of its clinical grade lentiviral vector, TNS 9.55.3, to Memorial Sloan Kettering Cancer Center.

29 Jul 2011

Amgen reports 8% increase in second quarter total product sales to $3,893 million

Amgen reported total revenue increased 4 percent during the second quarter of 2011 to $3,959 million versus $3,804 million in the second quarter of 2010. Total product sales increased 8 percent in the second quarter of 2011 to $3,893 million versus $3,613 million in the second quarter of 2010. The increase in total revenue in the second quarter of 2011 included a decline in other revenue due to certain milestone payments earned in the second quarter of 2010.

29 Jul 2011

Human kinome RNAi screening performed using Roche’s xCELLigence MP Instrument

RNA interference studies are a powerful technology for high-throughput screening. However, endpoint analyses only provide a snapshot of the analyzed cellular phenotype, as it is not possible to measure developmental changes over time.

29 Jul 2011